The first week of March 2025 proved to be a dynamic period for venture capital, with significant funding rounds underscoring robust investor confidence in transformative technologies and critical infrastructure. Leading the charge were groundbreaking innovations in space technology and the foundational layers of artificial intelligence, alongside substantial investments in healthcare, neuroscience, and enterprise solutions. This week’s top 10 U.S. startup funding deals collectively represent a formidable injection of capital, signaling key growth areas and the continued pursuit of ambitious ventures poised to redefine industries. The concentration of megadeals, particularly three exceeding half a billion dollars, highlights a strategic focus on sectors with long-term potential and high barriers to entry, where significant capital can accelerate development and market penetration.

  1. Sierra Space, $550M, Space Tech: Securing the largest round of the week, Louisville, Colorado-based Sierra Space, a prominent player in the space and defense technology sector, raised a staggering $550 million in equity funding. This substantial investment, led by LuminArx Capital Management, propelled the 5-year-old company to an impressive $8 billion valuation. Sierra Space is at the forefront of designing and manufacturing advanced satellites, versatile spacecraft, and critical space subsystems. Their portfolio includes the innovative Dream Chaser spaceplane, designed for cargo and potentially crewed missions to low-Earth orbit, and their pivotal role in the Orbital Reef commercial space station project alongside Blue Origin. This funding round is a testament to the growing investor appetite for commercial space ventures, recognizing Sierra Space’s dual capabilities in government contracts and the burgeoning private space economy. The capital infusion will undoubtedly accelerate the development and deployment of their next-generation space infrastructure, solidifying their position as a key enabler of future space exploration and utilization.

  2. (tied) Ayar Labs, $500M, AI Infrastructure: In a testament to the critical importance of underlying technology supporting the AI revolution, San Jose, California-based Ayar Labs landed a significant $500 million in Series E funding. This round, led by Neuberger Berman, valued the 11-year-old company at $3.75 billion. Ayar Labs specializes in producing co-packaged optics, a revolutionary technology designed to address the escalating data bottlenecks within AI infrastructure. As AI models grow exponentially in size and complexity, the ability to efficiently move vast amounts of data between processing units becomes paramount. Ayar Labs’ optical interconnect solutions promise to dramatically increase bandwidth, reduce latency, and lower power consumption, which are crucial for scaling AI data centers and enabling the next generation of AI supercomputers. This investment underscores the market’s recognition that hardware innovation, particularly in data transfer, is as vital as algorithmic advancements for the future of AI. The funds will be instrumental in scaling production and further developing their groundbreaking optical chiplet technology.

  3. (tied) Vast, $500M, Space Tech: Long Beach, California-based Vast, an ambitious startup focused on developing next-generation space stations, also announced a robust $500 million in fresh funding. This significant capital raise was structured with $300 million in Series A equity and an additional $200 million in debt financing, with Balerion Space Ventures leading the equity portion. Vast’s vision centers on creating habitable and economically viable space stations, potentially paving the way for in-space manufacturing, research, and long-duration human presence beyond Earth. Their recent announcement of plans for Haven-1, a commercial space station module, signals a bold step towards realizing this future. The substantial funding reflects a growing belief in the commercial viability of private space stations, moving beyond government-led initiatives. This capital will be crucial for accelerating the design, manufacturing, and eventual deployment of their modular space station architecture, positioning Vast as a frontrunner in the race to commercialize low-Earth orbit.

  4. Findhelp, $250M, Care Platform: Addressing the critical need for integrated social care, Austin-based Findhelp secured $250 million in investment from TPG’s The Rise Fund. Founded in 2010, Findhelp has developed a pioneering platform that facilitates the coordination of care across a diverse ecosystem including health systems, government agencies, benefits providers, and other community entities. Their mission is deeply rooted in connecting individuals to the vital help and support systems they need, effectively tackling social determinants of health. The platform streamlines access to resources for food, housing, transportation, financial assistance, and more, which are often fragmented and difficult to navigate. TPG’s The Rise Fund, known for its focus on impact investing, recognizes Findhelp’s proven ability to deliver measurable social good alongside strong business growth. This funding will enable Findhelp to expand its network, enhance its technological capabilities, and reach more communities, further bridging the gap between healthcare and social services.

  5. Science Corp., $230M, Neurotech: Alameda, California-based Science Corp., a biotech startup operating at the cutting edge of brain-computer interface (BCI) technologies, announced the close of a $230 million Series C fundraise. This syndicated round saw participation from a consortium of high-profile investors including Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT, and Quiet Capital. Science Corp. stands out with its focus on advanced neurotechnology, including a significant presence of ex-Neuralink alums, signaling a deep expertise in the field. BCI technology holds immense promise for treating neurological disorders, restoring lost sensory and motor functions, and potentially augmenting human capabilities. This substantial investment highlights the increasing interest and confidence in the commercialization of sophisticated neurotech solutions, despite the inherent complexities and regulatory hurdles. The funds will be critical for accelerating research and development, clinical trials, and scaling their innovative BCI platforms, bringing closer the reality of therapeutic and assistive brain interfaces.

  6. Cart.com, $180M, E-commerce: Houston-based Cart.com, a provider of a comprehensive e-commerce platform and integrated logistics services, secured $180 million in growth equity investment led by Springcoast Partners. In an increasingly competitive and complex digital retail landscape, Cart.com offers brands a full-stack solution to manage their online sales across various digital channels. This includes everything from storefront creation and order management to fulfillment, shipping, and marketing analytics. The platform aims to simplify the operational complexities of e-commerce, allowing brands to focus on product development and customer engagement. This growth capital injection will enable Cart.com to further expand its platform capabilities, enhance its logistics network, and accelerate its market penetration, empowering more businesses to thrive in the omnichannel retail environment. The investment reflects a continued belief in the e-commerce enablement sector, especially for solutions that offer end-to-end operational efficiency.

  7. Grow Therapy, $150M, Mental Health Care: Addressing the urgent and growing mental health crisis, New York-based Grow Therapy raised $150 million in Series D funding. The round was co-led by prominent investors TCV and Goldman Sachs Growth Equity. Grow Therapy operates a platform designed to connect individuals seeking mental health support with a diverse network of qualified therapists. By streamlining the process of finding, booking, and receiving care, the company aims to improve access to essential mental health services. Their model often focuses on supporting therapists in private practice, helping them manage administrative tasks, credentialing, and billing, thereby allowing them to concentrate on patient care. This significant investment underscores the sustained demand for accessible and affordable mental healthcare solutions. The capital will be used to expand Grow Therapy’s network of providers, enhance its technology platform, and reach more individuals in need of support, playing a vital role in destigmatizing and democratizing mental wellness.

  8. Cognito Therapeutics, $105M, Neuroscience: Cambridge, Massachusetts-based Cognito Therapeutics, a developer of novel therapies for neurodegenerative diseases, secured $105 million in Series C funding. This round was led by Morningside, IAG Capital Partners, and Starbloom Capital. Cognito Therapeutics is pioneering a non-invasive approach to treating neurodegenerative conditions like Alzheimer’s disease, utilizing proprietary gamma frequency stimulation technology. Their innovative method aims to modulate brain activity to potentially slow disease progression and improve cognitive function. Given the immense unmet medical need in neurodegenerative diseases and the challenges associated with traditional pharmaceutical approaches, Cognito’s unique therapeutic strategy has garnered significant investor interest. This funding will be critical for advancing their clinical trials, expanding their research efforts, and moving closer to bringing this potentially life-changing therapy to patients, offering new hope in a challenging medical field.

  9. Nominal, $80M, Engineering Software: Austin-based Nominal, a company that describes itself as a provider of cutting-edge tools for engineers to test and operate critical technology, picked up $80 million in new funding. This round, led by Founders Fund, set a robust $1 billion valuation for the company. Nominal’s software solutions are designed to address the complex challenges faced by engineers in high-stakes environments, such as aerospace, defense, and advanced manufacturing. Their tools likely involve sophisticated simulation, digital twin technologies, and operational analytics, enabling engineers to rigorously test, optimize, and manage complex systems before and during deployment. This investment and valuation reflect the increasing demand for advanced engineering software that can reduce development cycles, improve reliability, and enhance the performance of critical infrastructure and technological innovations. Founders Fund’s backing signals strong confidence in Nominal’s ability to become a foundational technology provider for the next generation of engineering.

  10. Sage, $65M, Health Software: Rounding out the top 10, New York-based Sage, a provider of a software platform tailored for senior living and skilled nursing facilities, raised $65 million in Series C funding led by Goldman Sachs Alternatives. As the global population ages, the demand for efficient and high-quality senior care solutions continues to grow exponentially. Sage’s platform aims to modernize and streamline operations within senior living communities and skilled nursing facilities, addressing critical challenges such as staff management, resident care coordination, health record management, and family communication. By providing a comprehensive, integrated software suite, Sage helps these facilities improve operational efficiency, enhance resident outcomes, and ensure compliance. This investment from Goldman Sachs Alternatives underscores the significant market opportunity in health tech solutions that cater to the elderly care sector, highlighting the need for technological innovation to support an aging demographic effectively.

Methodology:
The data for this weekly roundup was compiled by tracking the largest announced funding rounds within the Crunchbase database for U.S.-based companies. The reporting period covered February 28 through March 6, 2025. While diligent efforts are made to capture all significant deals, a minor time lag may occur for some rounds reported late in the week.

The first week of March 2025 has unequivocally demonstrated the venture capital market’s enthusiasm for transformative technologies. With space tech pushing the boundaries of human presence and commercial activity beyond Earth, and AI infrastructure laying the groundwork for unprecedented computational power, these sectors are clearly attracting substantial investment. Coupled with robust activity in specialized healthcare solutions, advanced engineering, and e-commerce enablement, the funding landscape paints a picture of strategic capital deployment aimed at solving complex problems and creating future growth engines across diverse industries. This sustained momentum suggests a dynamic year ahead for innovation and startup growth.